NCT02221999 2023-08-29
SHPD002
RenJi Hospital
Phase 2/3 Active not recruiting
Clinical Trials
6 trialsNCT02692755 2021-09-28
PALINA
Georgetown University
Phase 2/3 Completed
NCT03507465 2018-04-25
Letrozole Plus Low-Dose Metronomic Capecitabine Versus EC-T (Epirubicin/Cyclophosphamide Followed by Docetaxel) as Neoadjuvant Therapy for ER+/HER2-negative Breast Cancer
Guangdong Provincial People's Hospital
Phase 2/3 Unknown
NCT00684216 2017-09-14
Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer
The Netherlands Cancer Institute
Phase 2/3 Terminated
NCT00535418 2017-09-05
Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers
Novartis
Phase 2/3 Completed
NCT00333047 2009-11-19
Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy
Novartis
Phase 2/3 Completed